Inimex Pharmaceuticals' Series B Round

Inimex Pharmaceuticals raised a round of funding on June 13, 2008.

Inimex Pharmaceuticals, Inc. is focused on the development and commercialization of Innate Defense Regulators (IDRs), first in class drugs that selectively trigger the body's innate defenses without c…

Articles about Inimex Pharmaceuticals' Series B Round: